About FDA

Office of Hematology and Oncology Products (OHOP): Immediate Office

Office Director (Acting): Richard Pazdur, M.D.
Regulatory Information Specialist: Bertha Mejia

Deputy Director: (Acting) Amy McKee, M.D.
Associate Director for Oncology Sciences: Greg Reaman, M.D.
Associate Director for Clinical Science: Paul Kluetz, M.D.
Associate Director for Regulatory Affairs: Tamy Kim, Pharm.D.
Associate Director for Precision Therapeutics: Gideon Blumenthal, M.D.
Regulatory Scientist: (Acting) Jessica Boehmer, M.B.A.
Sr. Regulatory Health Project Manager: Karen Boyd, M.S.
Project Manager, Scientific Outreach (Editor): Kirsten Goldberg, M.A.

Oncology Program Project Management Team:
Lead Regulatory Health Project Manager: Dianne Spillman,B.S.
Regulatory Health Project Manager: Christine Lincoln, RN, M.S., MBA
Regulatory Health Project Manager/Staff Fellow: Jura Viesulas, EdD
Regulatory Health Project Manager: Sonia Swayze, RN, M.A.
Regulatory Health Project Manager: Valerie Vashio, BPharm, RPh
Regulatory Health Project Manager: Sherwin Sapasap, M.S., MBA, MHA
Regulatory Health Project Manager: Joan Todd, RN, M.S.

Technical Information Specialist: Tony Cossentino, B.S.

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Oncology Drug Products
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone:  (301) 796-2340
Fax: (301) 796-9909

Page Last Updated: 04/17/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English